Injective extends upward price move as buyers support rally
Injective (INJ) is trading at $7.48, gaining 7.33% on the day and nearing the high of its daily range with moderate volatility. The asset holds above its key moving averages across short and long-term timeframes.
Highlights
- Injective Institutional Rail is providing banks and enterprises with dedicated access to block production for predictable inclusion and instant transaction finality.
- Injective has processed over 1 billion transactions at sub-second block times, supporting an ecosystem of more than 100 projects and 500,000 community members.
- INJ/USD surged 7.33% to $7.48, with bullish structure and momentum signals; expected 1 to 2 day range is $6.89 to $7.79.
Institutional demand grows as block production rail boosts ecosystem
The launch of the Injective Institutional Rail is providing banks and enterprises with a specialized gateway to participate in Injective block production, enabling predictable inclusion and instant transaction finality. This development is expected to drive institutional demand and participation, with operational scalability highlighted by Injective's processing of more than 1 billion transactions at sub-second block times and high throughput. Broader engagement is also reflected in an ecosystem that now spans over 100 projects and more than 500,000 community members, according to Cryptowisser.
Bullish momentum persists as overbought signals limit upside
On the hourly chart, INJ trades above the MA-20 at $7.25 and MA-50 at $7.14, while the daily chart shows it holding well above the long-term MA-200 at $5.57. The $7.19 Ichimoku Kijun level offers immediate support for any pullbacks. Among indicators, MACD signals strong bullish momentum, while ADX remains neutral and Stoch RSI is overbought, flagging a possible short-term pause. RSI and CCI both read neutral, with Bull/Bear Power positive at 0.08, pointing to modest intraday buyer strength.
Continued range trade likely as breakout risks shape short-term
Over the next 1 to 2 days, price action is expected to remain within the $6.89–$7.79 range under typical volatility for the asset. The probability of continued upside is estimated at 71%, with a downside move at 29%. Most likely, INJ consolidates gains between these bounds; a breakout above resistance could bring further upward momentum, while a drop below immediate support may initiate a deeper pullback toward the lower end of the recent range.
Earlier, analysts noted that Injective had shifted to a downside bias, with technical screens highlighting the importance of holding above key support to avoid further weakness. The current rebound above moving averages and supportive indicator signals point to a potential scenario where traders monitor the $7.19 support for near-term direction, while a sustained move beyond resistance could reestablish bullish momentum.